甲状腺がん診断薬の世界市場レポート 2024

甲状腺がん診断薬の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には5.7%の年間複合成長率（CAGR）で37億米ドルに成長すると予想されます。予測期間で予想される成長は、コンパニオン診断に対する需要の高まり、個別化医療に対する患者の嗜好の高まり、経済成長、ヘルスケア支出の増加、医師の教育と訓練の強化、規制当局の承認と認可に起因すると考えられます。予測期間における注目すべき動向には、リキッドバイオプシーの出現、診断技術の世界化、技術進歩、研究開発への注目の高まり、診断における人工知能の統合、業界内の協力的な取り組みやパートナーシップが含まれます。

予想される甲状腺がん症例の増加は、甲状腺がん診断市場の拡大を促進すると予想されます。甲状腺に影響を及ぼす疾患である甲状腺がんは、治療成果を向上させるために早期発見が必要です。診断ツールは甲状腺がんを早期に特定する上で重要な役割を果たし、効果的な診断ソリューションに対する需要の高まりに応えています。米国がん協会の2023年9月の報告書によると、2023年には推定43,720人の新たな甲状腺がん症例が発生すると予想されており、診断の進歩の必要性が強調されています。報告書はさらに、同年に約2,120人が甲状腺がんにより死亡すると予測しています。したがって、甲状腺がんの罹患率の増加は、甲状腺がん診断市場を推進する重要な推進力となっています。

ヘルスケア支出の増加により、甲状腺がん診断薬市場はさらに拡大する見込みです。ヘルスケア提供に割り当てられる財源を含む医療支出は、ヘルスケア市場力学に影響を与える重要な要素です。ヘルスケアへの投資の増加は、高度な診断技術の調査、開発、実装に貢献します。この投資により、革新的なツールの入手しやすさと手頃な価格が向上し、甲状腺がんの早期発見と管理の改善が促進されます。メディケアとメディケイドのサービスセンターによる2021年から2030年の国民医療支出報告書に示されているように、国民医療支出の年間成長率は2021年から2030年の間に5.1%に達し、総額は約6兆8,000億米ドルに達すると予想されています。特にメディケアとメディケイドに重点を置くと、支出はそれぞれ年間7.2%と5.6%の割合で増加すると予想されます。したがって、ヘルスケア支出の増加は、甲状腺がん診断薬市場の成長を促進する主要な推進力です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の甲状腺がん診断市場促進要因と制約要因
  • 市場の促進要因
  • 市場の抑制要因
• 世界の甲状腺がん診断市場規模実績と成長、2018年から2023年
• 世界の甲状腺がん診断市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の甲状腺がん診断市場、技術タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 画像検査
• 血液検査
• 生検
• その他のテストの種類
• 世界の甲状腺がん診断市場、疾患別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 乳頭がん
• 濾胞がん
• その他の病気
• 世界の甲状腺がん診断市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院検査室
• がん診断センター
• 調査機関
• その他のエンドユーザー

第7章 地域および国の分析

• 世界の甲状腺がん診断市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の甲状腺がん診断市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 甲状腺がん診断市場の競合情勢
• 甲状腺がん診断市場の企業プロファイル
  • Pfizer Inc.
  • General Electric
  • F. Hoffmann-La Roche AG
  • Bayer AG
  • Novartis International AG

第31章 その他の大手および革新的な企業

• Sanofi SA
• Bristol-Myers Squibb Company
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• GlaxoSmithKline plc
• Canon Inc.
• Eli Lilly and Company
• Toshiba Corporation
• Merck KGaA
• Siemens Healthcare GmbH
• FUJIFILM Holdings Corporation
• Koninklijke Philips NV
• GE Healthcare
• AstraZeneca plc
• Agilent Technologies Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Thyroid cancer diagnostics involves the use of techniques to examine a lump or nodule suspected of being thyroid cancer, aiding in the identification and diagnosis of thyroid cancer. Thyroid cancer is a type of cancer that originates in the thyroid gland when cells undergo uncontrolled growth.

The primary techniques used in thyroid cancer diagnostics include imaging tests, blood tests, biopsies, and other diagnostic procedures. Imaging involves creating visual representations of phenomena such as temperature, sound waves, chemicals, or electrical activity. In the context of thyroid cancer diagnostics, imaging tests are utilized to generate images of the thyroid gland. Different types of thyroid cancer include papillary carcinoma, follicular carcinoma, and others. These diagnostic techniques are employed by various end-users, including hospital laboratories, cancer diagnostic centers, research institutes, and others.

The thyroid cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides thyroid cancer diagnostics market statistics, including thyroid cancer diagnostics industry global market size, regional shares, competitors with a thyroid cancer diagnostics market share, detailed thyroid cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the thyroid cancer diagnostics industry. This thyroid cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The thyroid cancer diagnostics market size has grown strongly in recent years. It will grow from $2.79 billion in 2023 to $2.97 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth observed in the historical period can be attributed to factors such as the increasing prevalence of thyroid cancer, an aging population, heightened awareness and early detection efforts, government initiatives and funding, as well as improvements in healthcare infrastructure.

The thyroid cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.7 billion in 2028 at a compound annual growth rate (CAGR) of 5.7%. The anticipated growth in the forecast period can be attributed to the growing demand for companion diagnostics, an increasing preference among patients for personalized medicine, economic growth, and higher healthcare spending, enhanced physician education and training, along with regulatory approvals and clearances. Noteworthy trends in the forecast period include the emergence of liquid biopsies, the globalization of diagnostic technologies, technological advancements, increased focus on research and development, the integration of artificial intelligence in diagnostics, as well as collaborative efforts and partnerships within the industry.

The anticipated increase in thyroid cancer cases is set to drive the expansion of the thyroid cancer diagnostic market. Thyroid cancer, a condition affecting the thyroid gland, necessitates early detection for improved treatment outcomes. Diagnostic tools play a crucial role in identifying thyroid cancer at an early stage, meeting the rising demand for effective diagnostic solutions. According to a September 2023 report by the American Cancer Society, an estimated 43,720 new cases of thyroid cancer are expected in 2023, emphasizing the need for diagnostic advancements. The report further projects approximately 2,120 deaths from thyroid cancer in the same year. Consequently, the escalating prevalence of thyroid cancer is a significant driver propelling the thyroid cancer diagnostic market.

The growth of healthcare spending is poised to further boost the thyroid cancer diagnostics market. Healthcare spending, encompassing financial resources allocated to healthcare provision, is a key factor influencing diagnostic market dynamics. The increased investment in healthcare contributes to the research, development, and implementation of advanced diagnostic technologies. This investment enhances accessibility and affordability of innovative tools, fostering early detection and improved management of thyroid cancer. As indicated in the 2021-2030 National Health Expenditure report by the Centers for Medicare & Medicaid Services, the projected annual growth in national health spending is expected to reach 5.1% between 2021 and 2030, totaling nearly $6.8 trillion. With specific focus on Medicare and Medicaid, spending is anticipated to rise at rates of 7.2% and 5.6% annually, respectively. Thus, increased healthcare spending is a key driver fueling the growth of the thyroid cancer diagnostics market.

Innovative product development, such as oral tablets, is a prominent trend among major companies in the thyroid cancer diagnostic market. Oral tablets, designed for oral administration, cater to a larger customer base and contribute to increased sales and revenue. For instance, Exelixis Inc. gained U.S. Food and Drug Administration (FDA) approval for CABOMETYX (cabozantinib) in September 2021. This oral tablet is approved for treating differentiated thyroid cancer (DTC) in adults and pediatric patients aged 12 and above. CABOMETYX tablets have received approvals for multiple indications, including advanced renal cell carcinoma (RCC), hepatocellular carcinoma, and the management of differentiated thyroid cancer (DTC) in adult and pediatric patients aged 12 and older.

Major companies in the thyroid cancer diagnostic market are also focusing on the development of innovative products, such as rearranged during transfection (RET) inhibitors. RET inhibitors specifically target and inhibit the activity of the RET protein. CStone Pharmaceuticals gained approval for GAVRETO (pralsetinib) in March 2022. GAVRETO is a selective RET inhibitor sanctioned in China for managing RET-mutant medullary thyroid cancer (MTC) and RET fusion-positive thyroid cancer (TC). This oral targeted therapy addresses the needs of patients with various forms of thyroid cancer, contributing to enhanced diagnostic and treatment options.

In August 2021, Veracyte Inc. acquired HalioDx for $279 million. This strategic acquisition empowers Veracyte Inc. to bring innovative diagnostic products to the market and further strengthens its position in cancer diagnostics. HalioDx, a France-based diagnostic company, offers immune-based diagnostic products and services, aligning with Veracyte's commitment to advancing cancer diagnostics.

Major companies operating in the thyroid cancer diagnostics market report are Pfizer Inc., General Electric, F. Hoffmann-La Roche AG, Bayer AG, Novartis International AG, Sanofi S.A., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, GlaxoSmithKline PLC, Canon Inc., Eli Lilly and Company, Toshiba Corporation, Merck KGaA, Siemens Healthcare GmbH, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., GE Healthcare, AstraZeneca PLC, Agilent Technologies Inc., Hologic Inc., Genzyme Corporation, Illumina Inc., BioMerieux SA, Bio-Rad Laboratories Inc., Quest Diagnostics Inc., Qiagen N.V., Cepheid, Veracyte Inc., DiaSorin S.p.A., Myriad Genetics Inc.

North America was the largest region in the thyroid cancer diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the thyroid cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The thyroid cancer diagnostics market includes revenues earned by entities by providing diagnostic tools related detection and diagnosis of thyroid cancer, radioactive tracer, biopsy, blood tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Thyroid Cancer Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on thyroid cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for thyroid cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The thyroid cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Technique Type: Imaging Test; Blood Test; Biopsy; Other Test Type
• 2) By Disease Type: Papillary Carcinoma; Follicular Carcinoma; Other Diseases
• 3) By End-User: Hospital Laboratories; Cancer Diagnostic Centers; Research Institutes; Other End-Users
• Companies Mentioned: Pfizer Inc.; General Electric; F. Hoffmann-La Roche AG; Bayer AG; Novartis International AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Thyroid Cancer Diagnostics Market Characteristics

3. Thyroid Cancer Diagnostics Market Trends And Strategies

4. Thyroid Cancer Diagnostics Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Thyroid Cancer Diagnostics Market Size and Growth

• 5.1. Global Thyroid Cancer Diagnostics Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Thyroid Cancer Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Thyroid Cancer Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Thyroid Cancer Diagnostics Market Segmentation

• 6.1. Global Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Imaging Test
• Blood Test
• Biopsy
• Other Test Type
• 6.2. Global Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Papillary Carcinoma
• Follicular Carcinoma
• Other Diseases
• 6.3. Global Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Laboratories
• Cancer Diagnostic Centers
• Research Institutes
• Other End-Users

7. Thyroid Cancer Diagnostics Market Regional And Country Analysis

• 7.1. Global Thyroid Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Thyroid Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Thyroid Cancer Diagnostics Market

• 8.1. Asia-Pacific Thyroid Cancer Diagnostics Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Thyroid Cancer Diagnostics Market

• 9.1. China Thyroid Cancer Diagnostics Market Overview
• 9.2. China Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Thyroid Cancer Diagnostics Market

• 10.1. India Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Thyroid Cancer Diagnostics Market

• 11.1. Japan Thyroid Cancer Diagnostics Market Overview
• 11.2. Japan Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Thyroid Cancer Diagnostics Market

• 12.1. Australia Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Thyroid Cancer Diagnostics Market

• 13.1. Indonesia Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Thyroid Cancer Diagnostics Market

• 14.1. South Korea Thyroid Cancer Diagnostics Market Overview
• 14.2. South Korea Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Thyroid Cancer Diagnostics Market

• 15.1. Western Europe Thyroid Cancer Diagnostics Market Overview
• 15.2. Western Europe Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Thyroid Cancer Diagnostics Market

• 16.1. UK Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Thyroid Cancer Diagnostics Market

• 17.1. Germany Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Thyroid Cancer Diagnostics Market

• 18.1. France Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Thyroid Cancer Diagnostics Market

• 19.1. Italy Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Thyroid Cancer Diagnostics Market

• 20.1. Spain Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Thyroid Cancer Diagnostics Market

• 21.1. Eastern Europe Thyroid Cancer Diagnostics Market Overview
• 21.2. Eastern Europe Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Thyroid Cancer Diagnostics Market

• 22.1. Russia Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Thyroid Cancer Diagnostics Market

• 23.1. North America Thyroid Cancer Diagnostics Market Overview
• 23.2. North America Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Thyroid Cancer Diagnostics Market

• 24.1. USA Thyroid Cancer Diagnostics Market Overview
• 24.2. USA Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Thyroid Cancer Diagnostics Market

• 25.1. Canada Thyroid Cancer Diagnostics Market Overview
• 25.2. Canada Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Thyroid Cancer Diagnostics Market

• 26.1. South America Thyroid Cancer Diagnostics Market Overview
• 26.2. South America Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Thyroid Cancer Diagnostics Market

• 27.1. Brazil Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Thyroid Cancer Diagnostics Market

• 28.1. Middle East Thyroid Cancer Diagnostics Market Overview
• 28.2. Middle East Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Thyroid Cancer Diagnostics Market

• 29.1. Africa Thyroid Cancer Diagnostics Market Overview
• 29.2. Africa Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Thyroid Cancer Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Thyroid Cancer Diagnostics Market Competitive Landscape
• 30.2. Thyroid Cancer Diagnostics Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. General Electric
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. F. Hoffmann-La Roche AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Bayer AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Novartis International AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Thyroid Cancer Diagnostics Market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. Bristol-Myers Squibb Company
• 31.3. Thermo Fisher Scientific Inc.
• 31.4. Abbott Laboratories
• 31.5. GlaxoSmithKline plc
• 31.6. Canon Inc.
• 31.7. Eli Lilly and Company
• 31.8. Toshiba Corporation
• 31.9. Merck KGaA
• 31.10. Siemens Healthcare GmbH
• 31.11. FUJIFILM Holdings Corporation
• 31.12. Koninklijke Philips N.V.
• 31.13. GE Healthcare
• 31.14. AstraZeneca plc
• 31.15. Agilent Technologies Inc.

32. Global Thyroid Cancer Diagnostics Market Competitive Benchmarking

33. Global Thyroid Cancer Diagnostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Thyroid Cancer Diagnostics Market

35. Thyroid Cancer Diagnostics Market Future Outlook and Potential Analysis

• 35.1 Thyroid Cancer Diagnostics Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Thyroid Cancer Diagnostics Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Thyroid Cancer Diagnostics Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer